LIC MF Healthcare Fund Direct Growth

LIC MF Healthcare Fund Direct Growth

Equity
Sectoral
High Risk
+21.16%
3Y annualised
-0.86% 1D
1M
6M
1Y
3Y
5Y
All
NAV: 19 Jan '26
₹31.28
Min. SIP amount
₹200
Fund size
₹83.12 Cr
Expense ratio
1.22%

Return calculator

One time
Monthly investment
₹5,000
Over the pastTotal investmentWould've becomeHistoric returnsReturns

Holdings (27)

NameSectorInstrumentsAssets
Sun Pharmaceutical Industries Ltd.HealthcareEquity10.85%
Torrent Pharmaceuticals Ltd.HealthcareEquity6.08%
Apollo Hospitals Enterprise Ltd.HealthcareEquity5.70%
Cipla Ltd.HealthcareEquity5.68%
Divi's Laboratories Ltd.HealthcareEquity4.74%
Neuland Laboratories Ltd.HealthcareEquity4.51%
Fortis Healthcare Ltd.HealthcareEquity4.48%
Aurobindo Pharma Ltd.HealthcareEquity4.46%
Piramal Pharma Ltd.HealthcareEquity4.32%
Onesource Specialty Pharma Ltd.HealthcareEquity3.88%
Abbott India Ltd.HealthcareEquity3.38%
Alkem Laboratories Ltd.HealthcareEquity3.32%
Concord Biotech Ltd.HealthcareEquity3.15%
Artemis Medicare Services Ltd.HealthcareEquity3.05%
Glenmark Pharmaceuticals Ltd.HealthcareEquity2.94%
Navin Fluorine International Ltd.ChemicalsEquity2.93%
Ipca Laboratories Ltd.HealthcareEquity2.83%
Gland Pharma Ltd.HealthcareEquity2.77%
Metropolis Healthcare Ltd.HealthcareEquity2.65%
Dr. Agarwal's Health Care Ltd.HealthcareEquity2.42%
Mankind Pharma Ltd.HealthcareEquity2.27%
Syngene International Ltd.HealthcareEquity2.21%
Global Health Ltd.HealthcareEquity2.13%
Max Healthcare Institute Ltd.HealthcareEquity2.11%
Anthem Biosciences Ltd.HealthcareEquity1.80%
Acutaas Chemicals Ltd.HealthcareEquity1.70%
Vinati Organics Ltd.ChemicalsEquity1.67%
See All

Minimum investments

Min. for 1st investment
₹5,000
Min. for 2nd investment
₹500
Min. for SIP
₹200

Returns and rankings

Annualised returns
Absolute returns
Name1Y3Y5YAll
Fund returns+0.5%+21.2%+12.6%+18.2%
Category average (Equity Sectoral)-2.1%+22.1%+14.6%--
Rank (Equity Sectoral)16910--

Exit load, stamp duty and tax

Exit load

Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.

Stamp duty on investment: 0.005% (from July 1st, 2020)

from July 1st 2020

Tax implication

If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data

Fund management

KD
Karan Doshi
Jul 2023 - Present
View details

About LIC MF Healthcare Fund Direct Growth

LIC MF Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by LIC Mutual Fund. This scheme was made available to investors on 20 Apr 1994. Karan Doshi is the Current Fund Manager of LIC MF Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹45,363 Cr and the Latest NAV as of 19 Jan 2026 is ₹31.28. The LIC MF Healthcare Fund Direct Growth is rated High risk. Minimum SIP Investment is set to ₹200. Minimum Lumpsum Investment is ₹5,000. Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days. ;

Investment Objective

The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
Fund benchmarkBSE Healthcare Total Return Index

Fund house

Rank (total assets)#20 in India
Total AUM₹45,363.42 Cr
Date of Incorporation20 Apr 1994
Phone022-66016177 / 022-66016178
Launch Date20 Apr 1994
AddressIndustrial Assurance BuildingGround Floor, Opp. Churchgate Station Mumbai 400020
CustodianSBI SG Global Securities Services Pvt.Ltd.
Registrar & Transfer AgentKFin Tech
AddressKarvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,